Video: SpaceX fires Super Heavy boosters ahead of Starship's 5th flight
The Super Heavy booster is designed to propel the Starship spacecraft into orbit. It is a crucial component of SpaceX's ambitious plans. Key Points
India TodayCovid Boosters Can’t Outpace New Mutations. Here’s Why They Still Work
The latest vaccines are designed to target XBB.1.5, the dominant variant throughout much of 2023—until now. Key Points
WIREDUS CDC signs off on second Omicron-updated COVID booster for older adults
Older people and those with weakened immune systems may get a second dose of Omicron-targeting COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention (CDC) said on Wednesday. Key Points
ReutersRBI banned Paytm Payment Bank, TCS' policy, Zuckerberg blames Apple & Google and more
In a significant move, India's central bank, the Reserve Bank of India (RBI), has imposed restrictions on fintech giant Paytm, prohibiting it from providing any forms of banking services to its customers. The RBI cited non-compliance and ongoing material supervisory concerns at One 97 Communications, the parent company of Paytm, as the reasons behind this decision.This new restriction imposed by the RBI could result in the disruption of several services offered by the Paytm platform. It is important to note the services that will remain functional and those that will be affected by this decision:Click here to read the full article Key Points
Times of IndiaDRDO successfully concludes four flight trials of ABHYAS
The Defence Research and Development Organisation (DRDO) achieves success with four flight trials of the high-speed expendable aerial target 'ABHYAS.' Conducted at Odisha's Integrated Test Range, the trials focused on key mission objectives, showcasing the effectiveness of the revised robust configuration with a single booster. ABHYAS, designed by DRDO's Aeronautical Development Establishment, serves as a cost-effective alternative for weapon system practice and holds export potential. Defence Minister Rajnath Singh congratulates DRDO for the achievement, emphasizing its significance in enhancing India's defence capabilities. Key Points
Economic Times
Biological E's Covid-19 vaccine CORBEVAX gets WHO emergency use listing
India Business News: Biological E's Covid-19 vaccine CORBEVAX has received emergency use listing from the World Health Organisation (WHO). The vaccine was approved in India for restricted use in emergency for adults, adolescents, and young children, as well as a heterologous booster dose for those aged 18 years and above. The Hyderabad-based vaccine maker has already supplied 100 million doses of CORBEVAX to the Indian government. The WHO EUL will help the company continue developing Covid-19 vaccines. Key Points
Times Of IndiaCovid-19 JN.1: Is your vaccine effective against the new variant?
While research on vaccine effectiveness against JN.1 is ongoing, booster doses could enhance protection by boosting the immune response, said expert. Key Points
India TodayL&T, BHEL and so many companies a part of Chandrayaan-3; check the list here
India's moon mission, Chandrayaan-3, successfully landed near the lunar south pole, making India the fourth nation to achieve this. Private sector companies such as Larsen and Tourbo's aerospace wing, Mishra Dhatu Nigam, Bharat Heavy Electricals, MTAR Technologies, Godrej Aerospace, Ankit Aerospace, and Walchandnagar Industries played crucial roles in supplying components and materials for the mission. Key Points
Economic TimesIndia’s first mRNA-based Omicron-specific booster vaccine from Pune-based Gennova gets DCGI approval
Gennova Biopharmaceuticals' mRNA Covid-19 booster vaccine, 'Gemcovac Om', has received emergency use authorisation from the office of the Drugs Controller General of India for the Omicron variant. The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. It is stable at two to eight degrees Centigrade and has been developed using Gennova's indigenous platform technology, supported under 'Mission Covid Suraksha'. Key Points
Hindustan Times